Aug 2026· Cell Genomics· Vol 6, pp. 101337· 1 citation· 196 references
Medicine
TL;DR
A generalizable single-cell and spatial transcriptomics framework that quantifies continuous damage trajectories in vivo using cell-type-specific scores that enable scalable mapping of degenerative disease progression and stage-specific therapeutic targets is introduced.
Abstract
Summary Degenerative diseases progress through gradual cell-intrinsic damage that is difficult to resolve with bulk transcriptomics or discrete cell-state analysis. We introduce a generalizable single-cell and spatial transcriptomics framework that quantifies continuous damage trajectories in vivo using cell-type-specific scores. Applied to chronic kidney disease and metabolic dysfunction-associated steatotic liver disease, the podocyte damage score (PDS) and hepatocyte damage score (HDS) place individual podocytes and hepatocytes on a health-to-damage axis. Across mouse and human single-cell RNA sequencing (scRNA-seq), single-nucleus RNA-seq (snRNA-seq), spatial transcriptomics, proteomics, histology, and clinical datasets, PDS and HDS robustly detect disease-associated damage, align disease models as well as unperturbed cells, and reveal conserved pathways. The PDS links podocyte injury and FSGS progression to circadian gene-expression disruption. The HDS identifies a damage threshold in metabolic dysfunction-associated steatotic liver disease (MASLD)/NASH beyond which hepatocytes adopt senescent, metabolically dysfunctional states. These damage scores enable scalable mapping of degenerative disease progression and stage-specific therapeutic targets.
Liver fibrosis is a defining feature of chronic liver diseases and can progress to cirrhosis and liver failure. Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity and multicellular interactions during fibrogenesis. In this narrative review, we analyzed published single-cel...
Wei-Wei Lu, Jun Xu, Ke-Xin Wang et al.· Frontiers in Immunology· 0 citations
This review provides a physiology-centered blueprint for applying single-cell RNA sequencing, single-nucleus RNA sequencing, and spatial transcriptomics to non-model species and critically evaluates dissociation and preservation bias, genome annotation, seasonal and ecological variation, biological replication, pseudor...
Adnan Amin, W. Zaman· Functional & Integrative Gen...· 0 citations
This review systematically integrates current evidence from sc/snRNA-seq studies, with a primary focus on brain-intrinsic mechanisms after ischemic stroke, to provide a structured synthesis of how sc/snRNA-seq has advanced the understanding of ischemic stroke biology.
Chang-Qing Mu, Yu-Chuan Ding, Alexander Weiss et al.· Frontiers in Neurology· 0 citations
Neuroinflammation and regulated cell death (RCD) are important components of secondary injury after acute ischemic stroke (AIS). However, the myeloid cell states involved in these processes and their spatial organization within ischemic brain tissue remain incompletely understood. This study aimed to characterize R...
Nan Jia, Jian-Qiao Li, He Yang et al.· Frontiers in Cell and Develo...· 0 citations
The mechanisms underlying type 2 diabetes-associated cognitive dysfunction (DACD) remain poorly understood, hindering therapeutic progress. Here, we integrated spatial transcriptomics and single-nucleus RNA sequencing to delineate the spatiotemporal molecular and cellular landscape of DACD in brain tissues from 3- and...
Wei Wu, Yu-Meng Yang, Xi-Xi Zhang et al.· Proceedings of the National...· 0 citations
An integrative, meta-cell based multiscale network analysis of snRNA-seq data from the substantia nigra to systematically uncover molecular mechanisms and identify potential therapeutic targets for Parkinson's Disease is developed.